Linnea’s Vincamine obtains a CEP certificate
The European Directorate for the Quality of Medicines & Healthcare (EDQM) has issued a CEP certificate for our Vincamine product, making Linnea the first company in the world to have a CEP-certified Vincamine extract.
CEP is a Certificate of Suitability to the monographs of the European Pharmacopoeia that centralizes the evaluation of the quality of pharmaceutical substances, and consequently certifies the compliance of the Active Pharmaceutical Ingredient (API) with the rules and specifications stated in the European Pharmacopoeia. Moreover, the CEP certification offers the advantage to speed up and simplify the regulatory lifecycle management in the countries where it is recognized.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance